✦ LIBER ✦

The first European study of lisdexamfetamine dimesylate in children and adolescents with ADHD: Overview

✍ Scribed by Coghill, D.R.; Banaschewski, T.; Lecendreux, M.; Soutullo, C.; Johnson, M.; Zuddas, A.; Anderson, C.; Civil, R.; Higgins, N.; Lyne, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Duration of response of lisdexamfetamine

✍ Zuddas, A.; Banaschewski, T.; Lecendreux, M.; Dittmann, R.W.; Hernández Otero, I 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 65 KB

Effect of lisdexamfetamine dimesylate on

✍ Soutullo, C.; Banaschewski, T.; Lecendreux, M.; Johnson, M.; Zuddas, A.; Bloomfi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 65 KB

EPA-1407 – The first European studies of

✍ Coghill, D.R.; Banaschewski, T.; Lecendreux, M.; Soutullo, C.; Johnson, M.; Zudd 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 76 KB

Health-related quality of life outcomes

✍ Banaschewski, T.; Johnson, M.; Zuddas, A.; Soutullo, C.; Hodgkins, P.; Bloomfiel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 61 KB

P.7.f.009 Lisdexamfetamine dimesylate: h

✍ Häge, A.; Dittmann, R.W.; Pennick, M.; Sorooshian, S.; Ermer, J.; Adeyi, B.; Squ 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 75 KB

P.7.c.009 Maintenance of efficacy of lis

✍ D. Coghill; T. Banaschewski; M. Lecendreux; M. Johnson; A. Zuddas; C. Anderson; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB